Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioServ Diagnostics, officially BioServ Analytik und Medizinprodukte GmbH, is a German biotechnology company specializing in the development and production of in vitro diagnostic (IVD) systems. Headquartered in Rostock, the company focuses on enzyme-linked immunosorbent assays (ELISA) for detecting infectious diseases and autoimmune disorders. Their extensive product portfolio includes specialized diagnostic kits for pathogens such as Borrelia, Toxoplasma, and various respiratory viruses. Beyond its proprietary product line, BioServ provides contract development and manufacturing services (CDMO) for third-party diagnostic components and kits. The company serves a global clientele of clinical laboratories, hospitals, and research institutions. BioServ maintains high quality standards, operating under ISO 13485 certification to ensure the reliability of its medical diagnostic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOSERV Diagnostics.